Erin Hodgson
Psychiatric/Mental Health · Sioux City, IANPI 1013516566
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,393 and has fallen 57.2% since, to $596 in 2025.
Across 319 payments — averaging $13.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$668
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$545
- Vanda Pharmaceuticals Inc.$530
- Supernus Pharmaceuticals, Inc.$386
- Otsuka America Pharmaceutical, Inc.$332
- Neurocrine Biosciences, Inc.$313
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,38399%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $668 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $545 |
| Vanda Pharmaceuticals Inc. | 24 | $530 |
| Supernus Pharmaceuticals, Inc. | 49 | $386 |
| Otsuka America Pharmaceutical, Inc. | 22 | $332 |
| Neurocrine Biosciences, Inc. | 24 | $313 |
| Lundbeck LLC | 16 | $300 |
| Alkermes, Inc. | 14 | $205 |
| Teva Pharmaceuticals USA, Inc. | 9 | $191 |
| Ironshore Pharmaceuticals Inc. | 16 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $170 |
| Johnson & Johnson | 9 | $138 |
| Corium, LLC | 11 | $104 |
| Neos Therapeutics, LP | 3 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Jazz Pharmaceuticals Inc. | 3 | $44 |
| Collegium Pharmaceutical, Inc. | 3 | $43 |
| Indivior Inc. | 3 | $43 |
| Eisai Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 2 | $27 |
| Merck | 2 | $25 |
| Tris Pharma Inc | 1 | $21 |
| Bausch Health US, LLC | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $12 |
| Neuronetics, Inc. | 1 | $9 |
How this compares
$4,436 in reported general payments places this provider in the 85th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Sioux City
- Melissa KonkenSioux City$14K
- Ricardo OsorioSioux City$8K
- Brenda CainSioux City$6K
- Danika HansenSioux City$5K
- Joada BestSioux City$4K
- Tyler LeskoSioux City$4K
- Cynthia GuthmillerSioux City$4K
- Monica NuckollsSioux City$4K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.